Video Series

In their closing thoughts, the panelists provide their key takeaways regarding immunizing against RSV.

BTK inhibitor implementation for MS treatment is explored.

The panelists provide insights into the decision-making process behind switching MS treatment strategies due to lacking or failed therapies.

Key opinion leaders discuss the value of real-world evidence in the management of HIV.

Assessing the quality of an HIV treatment plan is crucial to patient prognosis.

In her closing thoughts, Dr Filer provides insights into the unmet needs in the treatment of RSV.

Discussion surrounding promotion of RSV vaccine awareness is further discussed.

The panel offers strategies for being proactive .

Dr Haumschild leads a discussion surrounding patient and provider collaboration to avoid clinical inertia in MS treatment pathways.

Frontline treatment options and the benefits of early intervention of MS are illustrated.

Medical experts discuss the significance of pill burden in the HIV treatment pathway.

The role of and indication for long-acting injectables is highlighted as a treatment approach for HIV.

Experts discuss the financial needs for RSV vaccines through a payer lens.

Financial burden associated with RSV treatment is explored by a medical expert.

Experts highlight the potential obstacles for RSV vaccines.

Key opinion leaders highlight the MS treatment landscape.

An expert panel discusses cost burden associated with the treatment of MS.

The panelists provide their final thoughts regarding disparities in women’s health.

The treatment landscape for HIV is discussed by a panel led by Dr Welch.

Key opinion leaders discuss the influence of guideline-directed therapy in the treatment of patients with HIV.

Vaccine hesitancy is a significant barrier to optimal RSV vaccine rollout.

Experts discuss strategies to prepare for the oncoming respiratory diseases season.

Dr Filer highlights the considerations for the rollout of new RSV vaccines.

The pathophysiology and treatment of active and inactive MS are explored.

Ryan Haumschild, PharmD, MS, MBA, leads a discussion around the epidemiology of multiple sclerosis.

Drs Derek van Amerongen, Soyini Hawkins, Roxie Cannon Wells, and Sharon Deans highlight triple-negative breast cancer among underrepresented patient populations.

The panel highlights initiatives to aid women in early cervical cancer diagnosis and intervention.

An expert panel navigates stigmas and barriers inhibiting patients from achieving optimal care for HIV.

Dr Adam C. Welch drives a discussion highlighting disparities in health care equity affecting patients who receive an HIV diagnosis.

Wanda Filer, MD, MBA, FAAFP, provides an overview of the potential outcomes for patients of all ages with RSV.